INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 457m ago
HOUSE PTR57m ago
SEC 13F57m ago
ROBINHOOD CHAIN57m ago
GR
Corporate insider

Guerrero Ramiro

DirectorCIK 0001913253

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells6 / 0
Max Insider Score38
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
34
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$50K
37.6K sh
Sep 10, 2026Sep 14, 2026
traded Sep 10, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MAIA Biotechnology, Inc.Director · Aug 24, 2026
38
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY
$109K
78.2K sh
Aug 27, 2026
Sep 1, 2026
traded Aug 27, 2026
+5d
SEC FORM 4

Evidence

32
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$63K
46.6K sh
Aug 28, 2026Sep 1, 2026
traded Aug 28, 2026
+4dSEC FORM 4

Evidence

31
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$12K
8,931 sh
Aug 26, 2026Sep 1, 2026
traded Aug 26, 2026
+6dSEC FORM 4

Evidence

25
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$2,386
1,794 sh
Aug 24, 2026Aug 26, 2026
traded Aug 24, 2026
+2dSEC FORM 4

Evidence

29
GR
Guerrero RamiroDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$16K
11.9K sh
Aug 20, 2026Aug 24, 2026
traded Aug 20, 2026
+4dSEC FORM 4

Evidence